RACHEL NOVAK: Open Payments
NPI 1699550053 · SALEM, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 56 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $204 |
| AstraZeneca Pharmaceuticals LP | 5 | $186 |
| Janssen Pharmaceuticals, Inc | 5 | $183 |
| Dexcom, Inc. | 3 | $174 |
| Novo Nordisk Inc | 9 | $148 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Lilly USA, LLC | 3 | $61 |
| Ardelyx, Inc. | 3 | $61 |
Products named: SPRAVATO, Dexcom G6 Transmitter, UBRELVY, PENMENVY, BREZTRI, REXULTI, CAPLYTA, IBSRELA.
Industry payments across WI — which companies pay providers there.
